Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified. more
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | 0.28% | 0.6% |
| 1-Month Return | 4.17% | 3.45% |
| 3-Month Return | 13.65% | 3.96% |
| 6-Month Return | 13.69% | 13.85% |
| 1-Year Return | 45.4% | 20.6% |
| 3-Year Return | 64.3% | 73.65% |
| 5-Year Return | 29.3% | 73.98% |
| 10-Year Return | 32.18% | 255.61% |
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | 15.70% | 36.60% |
| 1-Month Return | 64.39% | 51.08% |
| 3-Month Return | 68.02% | 17.06% |
| 6-Month Return | 29.72% | 30.09% |
| 1-Year Return | 45.40% | 20.60% |
| 3-Year Return | 18.00% | 20.20% |
| 5-Year Return | 5.27% | 11.71% |
| 10-Year Return | 2.83% | 13.53% |
| Stock name | Ticker | Weight |
|---|---|---|
Amgen Inc | AMGN | 8.7% |
Vertex Pharmaceuticals Inc | VRTX | 8.27% |
Gilead Sciences Inc | GILD | 7.12% |
Regeneron Pharmaceuticals Inc | REGN | 5.52% |
Revolution Medicines Inc | RVMD | 2.93% |
Biogen Inc | BIIB | 2.07% |
Alnylam Pharmaceuticals Inc | ALNY | 2.01% |
Illumina Inc | ILMN | 1.96% |
Insmed Inc | INSM | 1.93% |
Royalty Pharma PLC | RPRX | 1.76% |
Roivant Sciences Ltd | ROIV | 1.75% |
Moderna Inc | MRNA | 1.7% |
Argenx SE | ARGNF | 1.62% |
Incyte Corp | INCY | 1.62% |
Guardant Health Inc | GH | 1.47% |
United Therapeutics Corp | UTHR | 1.46% |
Viatris Inc | VTRS | 1.26% |
Medpace Holdings Inc | MEDP | 1.15% |
Bridgebio Pharma Inc | BBIO | 1.1% |
Neurocrine Biosciences Inc | NBIX | 1.06% |
Ascendis Pharma A/S | ASND | 1.06% |
Jazz Pharmaceuticals PLC | JAZZ | 1.05% |
BioMarin Pharmaceutical Inc | BMRN | 0.91% |
Exelixis Inc | EXEL | 0.85% |
Madrigal Pharmaceuticals Inc | MDGL | 0.83% |
Arrowhead Pharmaceuticals Inc | ARWR | 0.83% |
Halozyme Therapeutics Inc | HALO | 0.81% |
BeOne Medicines Ltd | ONC | 0.8% |
Summit Therapeutics Inc | SMMT | 0.79% |
Axsome Therapeutics Inc | AXSM | 0.74% |
BioNTech SE | BNTX | 0.72% |
Praxis Precision Medicines Inc | PRAX | 0.72% |
Cytokinetics Inc | CYTK | 0.69% |
Sanofi SA | SNY | 0.68% |
Krystal Biotech Inc | KRYS | 0.66% |
Protagonist Therapeutics Inc | PTGX | 0.66% |
Tempus AI Inc | TEM | 0.64% |
Kymera Therapeutics Inc | KYMR | 0.63% |
Ionis Pharmaceuticals Inc | IONS | 0.63% |
Spyre Therapeutics Inc | SYRE | 0.61% |
Crinetics Pharmaceuticals Inc | CRNX | 0.6% |
Immunovant Inc | IMVT | 0.59% |
Vaxcyte Inc | PCVX | 0.58% |
Alkermes PLC | ALKS | 0.56% |
Apogee Therapeutics Inc | APGE | 0.56% |
ImmunityBio Inc | IBRX | 0.54% |
Rhythm Pharmaceuticals Inc | RYTM | 0.54% |
Twist Bioscience Corp | TWST | 0.52% |
Abivax SA | ABVX | 0.49% |
CG oncology Inc | CGON | 0.46% |
10X Genomics Inc | TXG | 0.45% |
Cogent Biosciences Inc | COGT | 0.45% |
Oruka Therapeutics Inc | ORKA | 0.44% |
Scholar Rock Holding Corp | SRRK | 0.43% |
Xenon Pharmaceuticals Inc | XENE | 0.42% |
Caris Life Sciences Inc | CAI | 0.42% |
Mirum Pharmaceuticals Inc | MIRM | 0.41% |
PTC Therapeutics Inc | PTCT | 0.4% |
Ligand Pharmaceuticals Inc | LGND | 0.4% |
Travere Therapeutics Inc | TVTX | 0.39% |
Erasca Inc | ERAS | 0.39% |
Amneal Pharmaceuticals Inc | AMRX | 0.38% |
CRISPR Therapeutics AG | CRSP | 0.35% |
ACADIA Pharmaceuticals Inc | ACAD | 0.34% |
Indivior Pharmaceuticals Inc | INDV | 0.32% |
Edgewise Therapeutics Inc | EWTX | 0.31% |
Definium Therapeutics Inc | DFTX | 0.31% |
Dyne Therapeutics Inc | DYN | 0.29% |
Relay Therapeutics Inc | RLAY | 0.29% |
Structure Therapeutics Inc | GPCR | 0.28% |
Adaptive Biotechnologies Corp | ADPT | 0.27% |
Denali Therapeutics Inc | DNLI | 0.27% |
Tango Therapeutics Inc | TNGX | 0.25% |
Kiniksa Pharmaceuticals International Plc | KNSA | 0.24% |
Veracyte Inc | VCYT | 0.24% |
Enliven Therapeutics Inc | ELVN | 0.24% |
Arcutis Biotherapeutics Inc | ARQT | 0.22% |
Newamsterdam Pharma Co NV | NAMS | 0.22% |
Ideaya Biosciences Inc | IDYA | 0.22% |
MBX Biosciences Inc | MBX | 0.21% |
AbCellera Biologics Inc | ABCL | 0.21% |
Alumis Inc | ALMS | 0.21% |
Disc Medicine Inc | IRON | 0.21% |
Tarsus Pharmaceuticals Inc | TARS | 0.2% |
Iovance Biotherapeutics Inc | IOVA | 0.2% |
GRAIL Inc | GRAL | 0.2% |
uniQure NV | QURE | 0.19% |
Supernus Pharmaceuticals Inc | SUPN | 0.19% |
Nurix Therapeutics Inc | NRIX | 0.18% |
Beam Therapeutics Inc | BEAM | 0.18% |
Kodiak Sciences Inc | KOD | 0.18% |
BioCryst Pharmaceuticals Inc | BCRX | 0.18% |
AtaiBeckley Inc | ATAI | 0.18% |
Ultragenyx Pharmaceutical Inc | RARE | 0.18% |
Amylyx Pharmaceuticals Inc | AMLX | 0.17% |
Pharvaris NV | PHVS | 0.17% |
Trevi Therapeutics Inc | TRVI | 0.17% |
Precigen Inc | PGEN | 0.16% |
UroGen Pharma Ltd | URGN | 0.16% |
Genmab A/S | GMAB | 0.16% |
Harmony Biosciences Holdings Inc | HRMY | 0.15% |
Vericel Corp | VCEL | 0.15% |
Rapport Therapeutics Inc | RAPP | 0.15% |
ADMA Biologics Inc | ADMA | 0.15% |
Ocular Therapeutix Inc | OCUL | 0.15% |
Mineralys Therapeutics Inc | MLYS | 0.15% |
Septerna Inc | SEPN | 0.15% |
Vera Therapeutics Inc | VERA | 0.14% |
GH Research PLC | GHRS | 0.14% |
Stoke Therapeutics Inc | STOK | 0.14% |
Novocure Ltd | NVCR | 0.14% |
Agios Pharmaceuticals Inc | AGIO | 0.14% |
Aurinia Pharmaceuticals Inc | AUPH | 0.13% |
Zenas Biopharma Inc | ZBIO | 0.13% |
Sarepta Therapeutics Inc | SRPT | 0.13% |
Compass Pathways Plc | CMPS | 0.13% |
Taysha Gene Therapies Inc | TSHA | 0.12% |
Zymeworks Inc | ZYME | 0.12% |
Syndax Pharmaceuticals Inc | SNDX | 0.12% |
Legend Biotech Corp | LEGN | 0.12% |
Fortrea Holdings Inc | FTRE | 0.12% |
Recursion Pharmaceuticals Inc | RXRX | 0.12% |
Xencor Inc | XNCR | 0.12% |
ANI Pharmaceuticals Inc | ANIP | 0.11% |
Intellia Therapeutics Inc | NTLA | 0.11% |
AnaptysBio Inc | ANAB | 0.11% |
Bicara Therapeutics Inc | BCAX | 0.11% |
First Tracks Biotherapeutics Inc | TRAX | 0.11% |
Immunocore Holdings PLC | IMCR | 0.1% |
Innoviva Inc | INVA | 0.1% |
Maze Therapeutics Inc | MAZE | 0.1% |
Vir Biotechnology Inc | VIR | 0.1% |
Tyra Biosciences Inc | TYRA | 0.1% |
Personalis Inc | PSNL | 0.1% |
Absci Corp | ABSI | 0.1% |
Harrow Inc | HROW | 0.1% |
Xeris Biopharma Holdings Inc | XERS | 0.1% |
ArriVent Biopharma Inc | AVBP | 0.1% |
Inhibrx Biosciences Inc | INBX | 0.1% |
ORIC Pharmaceuticals Inc | ORIC | 0.1% |
Monte Rosa Therapeutics Inc | GLUE | 0.09% |
Novavax Inc | NVAX | 0.09% |
Corvus Pharmaceuticals Inc | CRVS | 0.08% |
Replimune Group Inc | REPL | 0.08% |
Alvotech SA | ALVO | 0.08% |
Vor BioPharma Inc | VOR | 0.08% |
Cullinan Therapeutics Inc | CGEM | 0.08% |
MeiraGTx Holdings plc | MGTX | 0.08% |
MannKind Corp | MNKD | 0.08% |
Savara Inc | SVRA | 0.08% |
Eton Pharmaceuticals Inc | ETON | 0.08% |
EyePoint Inc | EYPT | 0.08% |
Sana Biotechnology Inc | SANA | 0.07% |
Janux Therapeutics Inc | JANX | 0.07% |
Wave Life Sciences Inc | WVE | 0.07% |
Geron Corp | GERN | 0.07% |
Omeros Corp | OMER | 0.07% |
Ardelyx Inc | ARDX | 0.07% |
Grifols SA | GRFS | 0.06% |
Castle Biosciences Inc | CSTL | 0.06% |
Pacira BioSciences Inc | PCRX | 0.06% |
Design Therapeutics Inc | DSGN | 0.06% |
Olema Pharmaceuticals Inc | OLMA | 0.06% |
Arbutus Biopharma Corp | ABUS | 0.06% |
Solid Biosciences Inc | SLDB | 0.06% |
Kura Oncology Inc | KURA | 0.06% |
Amphastar Pharmaceuticals Inc | AMPH | 0.06% |
Mesoblast Ltd | MESO | 0.06% |
Annexon Inc | ANNX | 0.06% |
Theravance Biopharma Inc | TBPH | 0.06% |
Maravai LifeSciences Holdings Inc | MRVI | 0.06% |
Zai Lab Ltd | ZLAB | 0.06% |
Invesco Government & Agency Portfolio | AGPXX | 0.06% |
Collegium Pharmaceutical Inc | COLL | 0.06% |
Aclaris Therapeutics Inc | ACRS | 0.05% |
Aura Biosciences Inc | AURA | 0.05% |
Candel Therapeutics Inc | CADL | 0.05% |
Rigel Pharmaceuticals Inc | RIGL | 0.05% |
CytomX Therapeutics Inc | CTMX | 0.05% |
Phathom Pharmaceuticals Inc | PHAT | 0.05% |
Allogene Therapeutics Inc | ALLO | 0.05% |
Phibro Animal Health Corp | PAHC | 0.05% |
Ironwood Pharmaceuticals Inc | IRWD | 0.05% |
Tectonic Therapeutic Inc | TECX | 0.05% |
Zevra Therapeutics Inc | ZVRA | 0.05% |
Silence Therapeutics PLC | SLN | 0.04% |
4D Molecular Therapeutics Inc | FDMT | 0.04% |
ARS Pharmaceuticals Inc | SPRY | 0.04% |
Neurogene Inc | NGNE | 0.04% |
Prime Medicine Inc | PRME | 0.04% |
Altimmune Inc | ALT | 0.04% |
Sagimet Biosciences Inc | SGMT | 0.04% |
Arvinas Inc | ARVN | 0.04% |
REGENXBIO Inc | RGNX | 0.04% |
CorMedix Inc | CRMD | 0.04% |
Evolus Inc | EOLS | 0.04% |
Aquestive Therapeutics Inc | AQST | 0.04% |
Contineum Therapeutics Inc | CTNM | 0.03% |
OmniAb Inc | OABI | 0.03% |
Kyverna Therapeutics Inc | KYTX | 0.03% |
Prothena Corp PLC | PRTA | 0.03% |
BioAge Labs Inc | BIOA | 0.03% |
Cabaletta Bio Inc | CABA | 0.03% |
Larimar Therapeutics Inc | LRMR | 0.03% |
Puma Biotechnology Inc | PBYI | 0.03% |
Editas Medicine Inc | EDIT | 0.03% |
C4 Therapeutics Inc | CCCC | 0.03% |
Autolus Therapeutics PLC | AUTL | 0.03% |
Lakefront Biotherapeutics NV | GLPGF | 0.03% |
Atea Pharmaceuticals Inc | AVIR | 0.03% |
Kamada Ltd | KMDA | 0.03% |
Alpha Teknova Inc | TKNO | 0.03% |
Enanta Pharmaceuticals Inc | ENTA | 0.03% |
Foghorn Therapeutics Inc | FHTX | 0.03% |
Lexeo Therapeutics Inc | LXEO | 0.03% |
Upstream Bio Inc | UPB | 0.02% |
Rocket Pharmaceuticals Inc | RCKT | 0.02% |
Pacific Biosciences of California Inc | PACB | 0.02% |
Lyell Immunopharma Inc | LYEL | 0.02% |
Immuneering Corp | IMRX | 0.02% |
Neumora Therapeutics Inc | NMRA | 0.02% |
Anavex Life Sciences Corp | AVXL | 0.02% |
Vanda Pharmaceuticals Inc | VNDA | 0.02% |
Entrada Therapeutics Inc | TRDA | 0.02% |
Sionna Therapeutics Inc | SION | 0.02% |
AC Immune SA | ACIU | 0.02% |
Orchestra BioMed Holdings Inc | OBIO | 0.02% |
Fulcrum Therapeutics Inc | FULC | 0.02% |
Keros Therapeutics Inc | KROS | 0.01% |
Invivyd Inc | ADGI | 0.01% |
Arcturus Therapeutics Holdings Inc | ARCT | 0.01% |
NovaBridge Biosciences | IMAB | 0.01% |
SIGA Technologies Inc | SIGA | 0.01% |
Pyxis Oncology Inc | PYXS | 0.01% |
PepGen Inc | PEPG | 0.01% |
Voyager Therapeutics Inc | VYGR | 0.01% |
Bicycle Therapeutics PLC | BCYC | 0.01% |
Coherus Oncology Inc | CHRS | 0.01% |
Lifecore Biomedical Inc | LNDC | 0.01% |
Caribou Biosciences Inc | CRBU | 0.01% |
Quantum-Si Inc | QSI | 0.01% |
Tenaya Therapeutics Inc | TNYA | 0.01% |
CASH & EQUIVALENTS | CASH...EQUIVALENTS | 0.01% |
LENZ Therapeutics Inc | LENZ | 0.01% |
Jyong Biotech Ltd | MENS | 0.01% |
Humacyte Inc | HUMA | 0.01% |
Codexis Inc | CDXS | 0.01% |
Aardvark Therapeutics Inc | AARD | 0.01% |
Black Diamond Therapeutics Inc | BDTX | 0.01% |
Rani Therapeutics Holdings Inc | RANI | 0.01% |
Gossamer Bio Inc | GOSS | 0% |
Cartesian Therapeutics Inc 12/31/2050 | Cartesian.Therapeutics.Inc.12.31.2050 | 0% |
USD Pending Dividends | USD.Pending.Dividends | 0% |
SECURITIES LENDING - BNYM | SECURITIES.LENDING...BNYM | 0% |
OmniAb Inc 11/02/2027 | OmniAb.Inc.11.02.2027 | 0% |
Esperion Therapeutics Inc 03/15/2028 | Esperion.Therapeutics.Inc.03.15.2028 | 0% |
Third Harmonic Bio Inc | THRD | 0% |
Eli Lilly & Co | Eli.Lilly...Co | 0% |
OmniAb Inc 11/02/2027 | OmniAb.Inc.11.02.2027 | 0% |
Novo Nordisk A/S 06/30/2031 | Novo.Nordisk.A.S.06.30.2031 | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Invesco Nasdaq Biotechnology ETF (IBBQ) share price today is $33.8122.
Yes, Indians can buy shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. To buy IBBQ from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. You can start investing in Invesco Nasdaq Biotechnology ETF (IBBQ) with a minimum investment of $1.
The 52-week high price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $34.34. The 52-week low price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $23.
The stock symbol (or ticker) of Invesco Nasdaq Biotechnology ETF is IBBQ.
Yes, you can setup SIP in Invesco Nasdaq Biotechnology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of IBBQ on the Vested app.
The expense ratio of Invesco Nasdaq Biotechnology ETF (IBBQ) is 0.19%.
Link copied